--- Article Not Found! ---
*** *** *** RSSing Note: Article is missing! We don't know where we put it!!. *** ***
View Article--- Article Not Found! ---
*** *** *** RSSing Note: Article is missing! We don't know where we put it!!. *** ***
View ArticleTogether with Siemens Healthineers, Varian Showcases Technologies and...
PALO ALTO, Calif., Oct. 20, 2022-- Varian, a Siemens Healthineers company, is highlighting its portfolio of intelligent, end-to-end imaging and cancer care technologies and services during the 2022...
View ArticlePhilips advances MR radiotherapy imaging and simulation for head and neck...
FDA 510(k) clearance for AI-enabled Philips MR for Calculating Attenuation (MRCAT) Head and Neck radiotherapy application expands range of MR-only workflows.read more
View ArticleGene mutations in tumors impact radiation sensitivity
Radiation therapy lags in the use of cancer genomics to guide treatments ‘Findings hasten a new paradigm in radiation therapy’ that can lead to more individualized treatments Discovery ultimately could...
View ArticleMevion Introduces New MEVION S250-FIT Proton Therapy System
This new compact system can fit in existing LINAC vaults, making proton therapy more accessible and affordable than ever before.read more
View ArticleMevion Identifies Site for New Compact Proton Therapy System in Development
The MEVION S250-FIT would be the first and only proton therapy system that can be installed in an existing LINAC vault.read more
View ArticleVarian and the Cincinnati Children's/University of Cincinnati Medical Center...
Varian, a Siemens Healthineers company, and the Cincinnati Children's/University of Cincinnati Medical Center Proton Therapy Center, today announced clinical trial results from FAST-01 ( F e A sibility...
View ArticleMevion Selected to Provide Proton Therapy Technology to the Froedtert & the...
LITTLETON, Mass., OCT 25, 2022 – Mevion Medical Systems is pleased to announce it has entered into a contract with the Froedtert & the Medical College of Wisconsin health network to bring the...
View ArticleCertain Head and Neck Cancer Survivors at Greater Risk for Long-Term...
October 25, 2022 Thomas J Galloway, MD, lead author on the study and associate professor in the Department of Radiation Oncology.read more
View ArticleMcLaren Proton Therapy Center Karmanos Cancer Institute, selects RayStation...
RaySearch Laboratories AB (publ) announces that McLaren Proton Therapy Center in Flint, Michigan, has placed an order for the treatment planning system RayStation®*.read more
View ArticleResults of a Study on Konica Minoltas Dynamic Digital Radiography by the...
Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare disease affecting approximately 4,000 patients in Japan. In patients with this disease, thrombus are chronically formed in the pulmonary...
View ArticlePhilips launches new compact ultrasound system at RSNA 2022, allowing...
New Ultrasound Compact System 5000 Series delivers premium image quality needed to aid in a confident diagnosis in a portable unit.read more
View ArticlePhilips debuts new AI-enhanced informatics solutions to increase diagnostic...
Philips introduces next-generation Advanced Visualization Workspace, including new cardiac MR Suite with new workflow and user interface, new AI powered CT ASPECT Scoring, and enhanced CT Liver...
View ArticleKintara Therapeutics Receives Orphan Drug Designation for VAL-083 for...
The FDA's ODD program provides orphan status to drugs defined as those intended for the treatment, diagnosis or prevention of rare diseases that affect fewer than 200,000 people. ODD provides the...
View Article
